Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents-Reference-Cited by-同舟云学术

Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents

Published:2009-11-03 Issue:9 Volume:151 Page:612
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Finckh Axel¹,Bansback Nick¹,Marra Carlo A.¹,Anis Aslam H.¹,Michaud Kaleb¹,Lubin Stanley¹,White Marc¹,Sizto Sonia¹,Liang Matthew H.¹

Affiliation:

1. From the University of Geneva, Geneva, Switzerland; University of British Columbia, Vancouver, British Columbia, Canada; University of Nebraska Medical Center, Omaha, Nebraska; National Data Bank for Rheumatic Diseases, Wichita, Kansas; and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis;JAMA Network Open;2024-06-26

2. Evaluation des Nutzens;Nutzen der Labormedizin in der Schweiz;2023

3. Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment;Expert Opinion on Biological Therapy;2022-07-03

4. The Impact of Traditional Chinese Medicine QingreHuoxue Treatment and the Combination of Methotrexate and Hydroxychloroquine on the Radiological Progression of Active Rheumatoid Arthritis: A 52-Week Follow-Up of a Randomized Controlled Clinical Study;Evidence-Based Complementary and Alternative Medicine;2022-04-12

5. Biosimilar Drug Development;Principles and Practice of Clinical Trials;2022